2610528J11Rik Activators encompass a diverse set of chemical compounds that facilitate the heightened functional activity of the protein through distinct signaling pathways. Forskolin, by elevating intracellular cAMP, indirectly augments the activity of 2610528J11Rik via PKA-dependent phosphorylation, a process 2610528J11Rik is implicated in. Ionomycin and A23187, both acting as calcium ionophores, enhance the protein's function by activating calcium-dependent kinases, thereby influencing signaling pathways involving 2610528J11Rik. PMA and Sphingosine-1-phosphate, targeting PKC and G-protein-coupled receptors respectively, potentiate 2610528J11Rik's activity through phosphorylation cascades. EGCG and Genistein, astyrosine kinase inhibitors, shift the phosphorylation balance by reducing competitive signaling, allowing for the preferential activation of pathways where 2610528J11Rik is a critical component.
The modulation of phosphoinositide 3-kinase (PI3K) signaling by LY294002 and Wortmannin provides an indirect route to enhancing 2610528J11Rik's activity by altering the phosphorylation landscape in which this protein operates. Similarly, the MEK inhibitor U0126 and the p38 MAPK inhibitor SB203580 recalibrate cellular signaling dynamics, tipping the scales towards processes that activate 2610528J11Rik. Staurosporine, a broad-spectrum kinase inhibitor, may paradoxically support 2610528J11Rik function by selectively inhibiting kinases that otherwise impede pathways involving 2610528J11Rik. Collectively, these activators work through nuanced modulation of cellular signaling, ensuring that 2610528J11Rik is preferentially activated, thereby enhancing its role in the specific biological processes it governs without directly increasing its expression or requiring direct binding to the protein.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent kinases that phosphorylate and enhance the activity of 2610528J11Rik through calcium signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to the phosphorylation and enhanced activity of 2610528J11Rik as part of a signaling cascade that 2610528J11Rik participates in. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its G-protein-coupled receptors, initiating signaling cascades that can lead to the activation of 2610528J11Rik through phosphorylation or other post-translational modifications. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a tyrosine kinase inhibitor that can enhance the activity of 2610528J11Rik by reducing competitive phosphorylation events, shifting the equilibrium toward pathways where 2610528J11Rik is activated. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, altering downstream signaling pathways, which can enhance the activity of 2610528J11Rik by modifying the phosphorylation status of proteins in the pathways that 2610528J11Rik regulates. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK and can enhance the activity of 2610528J11Rik by decreasing competitive signaling through the p38 MAPK pathway, which could suppress the pathways that activate 2610528J11Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, thus enhancing the activity of 2610528J11Rik through calcium-dependent signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a protein kinase inhibitor that, while broad-spectrum, can indirectly enhance the activity of 2610528J11Rik by inhibiting kinases that negatively regulate the pathways involving 2610528J11Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that leads to alterations in downstream signaling pathways, which can indirectly enhance the activity of 2610528J11Rik through the modification of signaling proteins that 2610528J11Rik interacts with. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can enhance the functional activity of 2610528J11Rik by reducing the activity of competitive tyrosine kinase signaling, which might suppress the pathways that activate 2610528J11Rik. | ||||||